345 related articles for article (PubMed ID: 6540757)
1. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of murine leukemia. VII. Prevention of Friend leukemia virus-induced immunosuppression by passive serum therapy.
Genovesi EV; Livnat D; Collins JJ
Int J Cancer; 1982 Nov; 30(5):609-24. PubMed ID: 6984021
[TBL] [Abstract][Full Text] [Related]
3. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Livnat D; Collins JJ
Leuk Res; 1982; 6(4):577-93. PubMed ID: 6958931
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
Collins JJ; Sackie DM; Johnson GR
Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
[TBL] [Abstract][Full Text] [Related]
7. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
Genovesi EV; Collins JJ
J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells.
Kumar V; Caruso T; Bennett M
J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in vitro induced by leukemia virus-infected splenocytes (38544).
Kamo I; Kateley JR; Kaplan G; Friedman H
Proc Soc Exp Biol Med; 1975 Feb; 148(2):383-6. PubMed ID: 1091933
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression induced in vitro by cell-free extracts of Friend leukemia virusinfected splenocytes.
Specter S; Patel C; Friedman H
J Natl Cancer Inst; 1976 Jan; 56(1):143-7. PubMed ID: 768498
[TBL] [Abstract][Full Text] [Related]
11. Modulation of natural killer (nk) cell activity during FLV-P virus infection of mice.
Migliorati G; Jezzi T; Frati L; Bonmassar E; Rossi GB; Garaci E; Riccardi C
Int J Cancer; 1983 Jan; 31(1):81-90. PubMed ID: 6219962
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
Friedman H; Kateley JR
Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy of Friend leukemia with antiserum (author's transl)].
Lynn TC; Metzgar RS
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):94-104. PubMed ID: 7449527
[TBL] [Abstract][Full Text] [Related]
15. Friend virus-induced immunodepression: effect of neuraminidase treatment on Thy-1.2 antigen expression and cytotoxic potential of splenocytes from virus-infected mice.
Mascio AA; Ceglowski WS
Infect Immun; 1978 Feb; 19(2):486-92. PubMed ID: 305416
[TBL] [Abstract][Full Text] [Related]
16. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia.
Wirth JJ; Levy MH; Wheelock EF
J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537
[TBL] [Abstract][Full Text] [Related]
17. Suppression of natural killer cell activity by Friend murine leukemia virus.
Moody DJ; Specter S; Bendinelli M; Friedman H
J Natl Cancer Inst; 1984 Jun; 72(6):1349-56. PubMed ID: 6202923
[TBL] [Abstract][Full Text] [Related]
18. Factors from lymphoid cell tumor affecting immune responses.
Specter S; Schneider R; Friedman H
Ann N Y Acad Sci; 1979; 332():531-8. PubMed ID: 394642
[TBL] [Abstract][Full Text] [Related]
19. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus.
Butler RC; Frier JM; Chapekar MS; Graham MO; Friedman H
Infect Immun; 1983 Mar; 39(3):1260-4. PubMed ID: 6220970
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice.
Genovesi EV; Livnat D; Collins JJ
J Natl Cancer Inst; 1983 Feb; 70(2):311-22. PubMed ID: 6337292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
